pharma · Lymphoma · Gastrointestinal Stromal Tumors · COGT
Cogent Biosciences
Cogent Biosciences patent portfolio — 10 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451, US
- Founded
- 2014
- Employees
- 283
- Programs
- 13
- Drugs
- 8
- Patents
- 10
Cogent Biosciences patents
10 pharmaceutical patents indexed for Cogent Biosciences. 0 expire within 24 months.
Cogent Biosciences has 10 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12351581
Compounds for FGFR inhibition
granted -
US 12281122
PI3K inhibitors
granted -
US 11718576
Compositions and methods comprising resveratrol
granted -
US 11339112
Compositions and methods comprising resveratrol
granted -
US 10836702
Compositions and methods comprising resveratrol
granted -
US 10449129
Encapsulates of salicylic acid and polysalicylic acid derivatives
granted -
US 10301248
Compositions and methods comprising resveratrol
granted -
US 6610295
Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
expired -
US 6432395
Cleaning composition containing naturally-derived components
expired -
US 6162620
Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
expired
Frequently asked questions
How many patents does Cogent Biosciences have?
10 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Cogent Biosciences patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.